Tag Archives: Memorial Sloan-Kettering Cancer Center

Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for RNA Sequencing based FoundationOne® Heme Assay


CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Foundation Medicine, Inc. (NASDAQ:FMI) and Memorial Sloan Kettering Cancer Center (MSK) today announced the publication of new, seminal data validating FoundationOne® Heme – the fully informative comprehensive genomic profiling assay for hematologic malignancies developed as ...

Read More »